These effects can help reduce calorie intake and support healthy weight management when combined with lifestyle changes
This causes a prolonged feeling of fullness -Semaglutide also acts on GLP-1 receptors in the brain which reduces appetite and lowers overall calorie intake
Tirzepatide reduces it disproportionately which is why the metabolic improvements seen in the SURPASS diabetes trials, including HbA1c reductions of 2.02.3%, were among the largest ever documented for any antidiabetic medication
IL-6: another key cytokine that promotes inflammation and is involved in conditions like asthma, atherosclerosis, cancer, depression, heart disease, AIDS, kidney injury, and sepsis
Youre getting complete medical care
Reading the SURMOUNT and SURPASS record Zepbound's weight-management evidence comes from the SURMOUNT program (with SURMOUNT-OSA covering sleep apnea), while Mounjaro's glycemic and weight data come from the SURPASS program in type 2 diabetes
